LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
H.R.601/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Medical/Disease Research/Clinical Labs MED
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. Unique Device Identifier proposed rule; Provisions regarding date format.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
| AMY MUHLBERG | N/A |
Budget/Appropriations BUD
S. 1599, sequestration: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. FY 2013 Agriculture Appropriations: Provisions regarding FDA appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.